The wait has been on the edge and the government officials are relieved that there is a third vaccine available in the market.
Johnson & Johnson’s one-shot vaccine that works against the COVID-19 has been finally approved by the FDA to fight against the pandemic.
FDA Has Finally Approved Johnson & Johnson’s 1-Shot Vaccine Against COVID-19
Pfizer and Moderna vaccines require 2 shots to complete the session, eventually boosting one’s immune system. With the J&J vaccine, you don’t have to return for your second dose of the vaccine. The vaccine requires only a single shot and can be easily kept in the refrigerator for a long time.
The federal government has been thinking of distributing around 4 million J&J doses to states, health centers, and pharmacies to every part of the nation by next week.
Now there is a third vaccine approved for emergency use, the fight against the pandemic has eased things for the United States. The new strains of the virus have been circulating all over the nation and the approval of the Johnson & Johnson vaccine has given hope to the residents against the contagious disease.
Johnson & Johnson’s vaccine will be easy for the officials to incorporate in their vaccination plan across the nation. Since the Pfizer and Moderna vaccines are dual shot vaccines, J&J one-shot vaccines stand out from the rest and ease the emergency disposal of vaccines to people in need. For people living in communities who are having a difficult time accessing the vaccine sites, this one-shot vaccine will be very helpful.
Johnson& Johnson are expected to release only a limited dose of the vaccine. Only by end of March, they will be delivering the 20 million doses of the vaccine, as claimed by Johnson & Johnson’s vice president of medical affairs- Dr. Richard Nettles. The Johnson & Johnson Company has agreed on a deal with the U.S. government to supply 100 million doses of the COVID vaccine towards June end. The government officials have stated that they are working closely with the company to speed up the vaccine supply at the earliest.
Recently, American residents were pushed by healthcare officials to get their vaccinations done because they were concerned about the new variants of the contagious virus, especially the B.1.251 variant.
The head of the Center for Disease Control and Prevention Rochelle Walensky claimed the COVID19 decline since January may have flattened, with variants starting to spread.
J&J vaccine is said to be effective and will prevent 100% of hospitalization and deaths. They had submitted their vaccine data on February 4th and expect a sudden improvement against the virus. Pfizer vaccine was 95% effective against the coronavirus whereas MOdern was 94% effective. Experts say that the J&J data on trials conducted cannot be compared with that of Pfizer and Moderna, since there were old and new contagious variants during the trials.
Talking about the approval, J&J, Pfizer, and Modera has only submitted 2 months of safety data when 6 months of data is required by the FDA for full approval. But J&J was approved on an emergency use against the new strains of the virus that have been spreading. The FDA had earlier approved hydroxychloroquine to treat the spread of the virus in March 2020. But they revoked it in June after the data showed no evidence that the medicine treated coronavirus patients.
Dr. Archana Chaterjee, an infectious disease expert, Chicago Medical School said that Johnson & Johnson’s has been a necessity at the moment as many states are having a very low supply of Pfizer and Moderna vaccines to treat infected patients.